Ophthalmologist looks ahead amid company’s advances over past 18 months.
Terry Kim, MD
Advertisement
Articles by Terry Kim, MD
Novel agent with mucus-penetrating nanoparticle marries potency, safety, convenience
Advertisement
Latest Updated Articles
Considering BID ocular steroid post-cataract surgeryPublished: May 16th 2019 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Starting from scratch on neovascular age-related macular degeneration
2
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
3
Rethinking punctal occlusion as an option for allergic conjunctivitis
4
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
5
.png "Optometry Times"){kind=logo}
